tirzepatide vs semaglutide results led to greater real-world weight loss than for adults with obesity Tirzepatide vs. Semaglutide: Which Weight

Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that was recently approved by the FDA for the treatment of type 2 diabetes

It may be appropriate if youre an adult with a raised BMI, particularly where weight is affecting your health

The syringe also has a thinner barrel diameter, which magnifies small volume differences and improves measurement precision

The difference is in the dosing

the FDA noted that repeated lapses demonstrate that executive management oversight and control over drug manufacture are inadequate and directed Empower to engage a third-party consultant with sterile drug manufacturing expertise State actions at least a dozen states have brought actions against Empower within the last decade, including a California State Board of Pharmacy disciplinary order Eli Lilly lawsuits Eli Lilly filed two separate lawsuits against Empower: one in April 2025 and another in July 2025, alleging unlawful manufacturing and misleading marketing of tirzepatide products